Epitomee Medical Stock Net Asset
| EPIT Stock | 947.50 10.50 1.10% |
Epitomee Medical fundamentals help investors to digest information that contributes to Epitomee Medical's financial success or failures. It also enables traders to predict the movement of Epitomee Stock. The fundamental analysis module provides a way to measure Epitomee Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Epitomee Medical stock.
Epitomee |
Epitomee Medical Company Net Asset Analysis
Epitomee Medical's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
| Competition |
Based on the recorded statements, Epitomee Medical has a Net Asset of 0.0. This indicator is about the same for the Healthcare average (which is currently at 0.0) sector and about the same as Medical Devices (which currently averages 0.0) industry. This indicator is about the same for all Israel stocks average (which is currently at 0.0).
Epitomee Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Epitomee Medical's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Epitomee Medical could also be used in its relative valuation, which is a method of valuing Epitomee Medical by comparing valuation metrics of similar companies.Epitomee Medical is currently under evaluation in net asset category among its peers.
Epitomee Fundamentals
| Current Valuation | 339.18 M | |||
| Shares Outstanding | 29.58 M | |||
| Shares Owned By Insiders | 56.83 % | |||
| Shares Owned By Institutions | 20.28 % | |||
| Price To Book | 3.48 X | |||
| Market Capitalization | 318.32 M |
About Epitomee Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Epitomee Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Epitomee Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Epitomee Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Epitomee Stock
Epitomee Medical financial ratios help investors to determine whether Epitomee Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Epitomee with respect to the benefits of owning Epitomee Medical security.